However, other studies demonstrate a tumor-suppressive role of DGCR5 in lung cancer (Chen et al., 2017; Luo et al., 2018), gastric cancer (Xu et al., 2019), bladder cancer (Fang et al., 2019), and cervical cancer (Liu et al., 2019). Here, DGCR5 is linked to lung carcinoma.